Library / Laws / 118th Congress / House Bills / H.R. 1825
H.R. 1825
To clarify that the Federal Right to Try law applies to schedule I substances for which a phase I clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the Federal Right to Try law.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2023-03-28 | 2.1K | ⠃⠗⠋ |